Citation Impact
Citing Papers
( R )-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
2013 StandoutScienceNobel
Initiating and Cancer-Propagating Cells in TEL-AML1 -Associated Childhood Leukemia
2008 Science
Anti-CD38 antibody–mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells
2008
Evolution of the Cancer Stem Cell Model
2014 Standout
Acute B lymphoblastic leukaemia‐propagating cells are present at high frequency in diverse lymphoblast populations
2012
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
Hif-2α is not essential for cell-autonomous hematopoietic stem cell maintenance
2013 StandoutNobel
Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice
2009
Cancer Stem Cells
2006
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Dexrazoxane does not protect against doxorubicin-induced damage in young rats
2003
Vincristine-induced peripheral neuropathy in children with cancer: A systematic review
2017
Target for cancer therapy: proliferating cells or stem cells
2005
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines
2006 Standout
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
2012 Standout
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
2011 StandoutNature
The DSIF Subunits Spt4 and Spt5 Have Distinct Roles at Various Phases of Immunoglobulin Class Switch Recombination
2012 StandoutNobel
Autoinflammatory Disease Reloaded: A Clinical Perspective
2010 Standout
Wnt signaling in cancer
2016 Standout
Metabolic Regulation of Hematopoietic Stem Cells in the Hypoxic Niche
2011 StandoutNobel
Forebrain ependymal cells are Notch-dependent and generate neuroblasts and astrocytes after stroke
2009 StandoutNobel
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer
2007 Standout
Cytokine-dependent imatinib resistance in mouse BCR-ABL+, Arf-null lymphoblastic leukemia
2007
The therapeutic promise of the cancer stem cell concept
2010
DNA methylation: roles in mammalian development
2013 Standout
The bone marrow niche for haematopoietic stem cells
2014 StandoutNature
In Childhood Acute Lymphoblastic Leukemia, Blasts at Different Stages of Immunophenotypic Maturation Have Stem Cell Properties
2008
ROS Function in Redox Signaling and Oxidative Stress
2014 Standout
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
2008 Standout
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia
2006
Metazoan MicroRNAs
2018 Standout
Molecular Determinants of Regulatory T Cell Development: The Essential Roles of Epigenetic Changes
2013 StandoutNobel
Extracellular matrix structure
2015 Standout
Caspase Functions in Cell Death and Disease
2013 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Vincristine: Can its therapeutic index be enhanced?
2009
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Dynamic regulation of stem cell specification and maintenance by hypoxia-inducible factors
2015 StandoutNobel
Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation
2008 Nature
DNA Methylation Dynamics during In Vivo Differentiation of Blood and Skin Stem Cells
2012
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
The cancer stem cell: premises, promises and challenges
2011 Standout
The promise of Janus kinase inhibitors in the treatment of hematological malignancies
2016
Primary brain tumours in adults
2012 Standout
Impaired DNA Replication within Progenitor Cell Pools Promotes Leukemogenesis
2005
ROS Are Good
2016 Standout
Clonal evolution in cancer
2012 StandoutNature
The functions and regulation of the PTEN tumour suppressor
2012 Standout
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
2017 Standout
Non-Stem Cell Origin for Oligodendroglioma
2010
Regulation of the HIF-1α Level Is Essential for Hematopoietic Stem Cells
2010
Flow cytometry in cancer stem cell analysis and separation
2012
Radial glia cells are candidate stem cells of ependymoma
2005
Genetic variegation of clonal architecture and propagating cells in leukaemia
2010 Nature
Human Chromosomal Translocations at CpG Sites and a Theoretical Basis for Their Lineage and Stage Specificity
2008
Cancer stem cells: an evolving concept
2012
A Perivascular Niche for Brain Tumor Stem Cells
2007 Standout
Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype
2014 StandoutNobel
Phenotypic characterization of human colorectal cancer stem cells
2007 Standout
Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1α to promote cell-cycle progression
2014 StandoutNobel
An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells
2007 Standout
Epigenetic control of thymic Treg‐cell development
2014 StandoutNobel
The Mechanism of Double-Strand DNA Break Repair by the Nonhomologous DNA End-Joining Pathway
2010 Standout
Adult hematopoietic stem cells lacking Hif-1α self-renew normally
2016 StandoutNobel
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Spontaneous Transformation of Cultured Mouse Bone Marrow–Derived Stromal Cells
2006 StandoutNobel
Cancer Genome Landscapes
2013 StandoutScience
AKT1 and AKT2 maintain hematopoietic stem cell function by regulating reactive oxygen species
2010
Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance
2010
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
HMG-CoA reductase inhibition induces IL-1β release through Rac1/PI3K/PKB-dependent caspase-1 activation
2008
Regulation of cell proliferation by hypoxia-inducible factors
2015 StandoutNobel
Evolutionary Comparison of the Mechanism of DNA Cleavage with Respect to Immune Diversity and Genomic Instability
2012 StandoutNobel
Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment
2011
miR-223 Deficiency Increases Eosinophil Progenitor Proliferation
2013
Works of Anders Castor being referenced
Vincristine pharmacokinetics is related to clinical outcome in children with standard risk acute lymphoblastic leukemia
2008
Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: Multi‐institutional collaborative study
2002
Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia
2005
Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study
2012
Vincristine in childhood leukaemia: no pharmacokinetic rationale for dose reduction in adolescents
2003
High GATA-2 expression inhibits human hematopoietic stem and progenitor cell function by effects on cell cycle
2009
Protein kinase B (c-akt) regulates hematopoietic lineage choice decisions during myelopoiesis
2007
Differential regulation of granulopoiesis by the basic helix-loop-helix transcriptional inhibitors Id1 and Id2
2005